VHOSPITAL.CLINIC · Referencia de farmacos
Resumen clinico para navegacion en espanol.
This medication belongs to a class of agents used in specific medical conditions. Prescribing, dosing, and monitoring requirements vary by individual patient needs and concurrent medications.
Used as directed by a healthcare professional for the specific indication for which it has been prescribed.
Follow prescriber's instructions. Report any unusual symptoms. Do not stop without medical advice for most medications.
Sitagliptin
Sitagliptin is a DPP-4 inhibitor that enhances incretin hormone activity to lower blood glucose in type 2 diabetes with low hypoglycemia risk.
Saxagliptin
Saxagliptin is a DPP-4 inhibitor that enhances incretin hormone activity to lower blood glucose in type 2 diabetes with low hypoglycemia risk.
Alogliptin
Alogliptin is a DPP-4 inhibitor that enhances incretin hormone activity to lower blood glucose in type 2 diabetes with low hypoglycemia risk.
Linagliptin
Linagliptin is a DPP-4 inhibitor that enhances incretin hormone activity to lower blood glucose in type 2 diabetes with low hypoglycemia risk.
Describe tus sintomas y contexto clinico para obtener una evaluacion estructurada con posibles causas y senales de alerta.
Iniciar analisis AI gratis →Aviso medico: Esta referencia farmacologica es informativa y no reemplaza la consulta medica profesional. Antes de iniciar, suspender o cambiar un medicamento, consulta con un profesional sanitario.